Because "adoption of a multiplexed method that can facilitate 'detection and differentiation of SARS-CoV-2 and influenza viruses' " means there is not a current capability in the existing tests. Otherwise they wouldn't need to adopt one. And those who need to adopt one were already using the CDC 2019 nCoV RT-PCR assay select, meaning that was likely the best available.
I should clarify further. Detection and differentiation of COVID and influenza means they look the same to the current test and they need something that can tell them apart. So the current test since 2019 has had no idea what it was looking at and they want a multiplexed method (can see more than one).
It's been bullshit this whole time. People have just been dying of flu, some of COVID, but we have no idea how many of each.
Because "adoption of a multiplexed method that can facilitate 'detection and differentiation of SARS-CoV-2 and influenza viruses' " means there is not a current capability in the existing tests. Otherwise they wouldn't need to adopt one. And those who need to adopt one were already using the CDC 2019 nCoV RT-PCR assay select, meaning that was likely the best available.
I should clarify further. Detection and differentiation of COVID and influenza means they look the same to the current test and they need something that can tell them apart. So the current test since 2019 has had no idea what it was looking at and they want a multiplexed method (can see more than one).
It's been bullshit this whole time. People have just been dying of flu, some of COVID, but we have no idea how many of each.
Thanks for the explanation!